Cigna Total Cost of Revenue decreased by 6.4% to $54.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $48.40B to $54.10B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 16.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.00B | $30.07B | $31.25B | $29.81B | $31.15B | $31.78B | $32.09B | $31.46B | $33.44B | $33.64B | $35.26B | $41.43B | $44.49B | $47.57B | $49.02B | $48.40B | $53.27B | $55.53B | $57.80B | $54.10B |
| QoQ Change | — | +3.7% | +3.9% | -4.6% | +4.5% | +2.0% | +1.0% | -2.0% | +6.3% | +0.6% | +4.8% | +17.5% | +7.4% | +6.9% | +3.1% | -1.3% | +10.1% | +4.2% | +4.1% | -6.4% |
| YoY Change | — | — | — | — | +7.4% | +5.7% | +2.7% | +5.5% | +7.4% | +5.9% | +9.9% | +31.7% | +33.0% | +41.4% | +39.0% | +16.8% | +19.7% | +16.7% | +17.9% | +11.8% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Evernorth Health Services | $51.12B | $54.94B | $57.33B | $59.70B | $55.70B |
| Cigna Healthcare | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $48.40B | $53.27B | $55.53B | $57.80B | $54.10B |